Toshio Matsumoto
8PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 29, 2023
The effects of abaloparatide on hip geometry and biomechanical properties in Japanese osteoporotic patients assessed using DXA-based hip structural analysis: results of the Japanese phase 3 ACTIVE-J trial.Teruki Sone, Kazuhiro Ohnaru, Takumi Sugai
|Sep 06, 2023
VDR is an essential regulator of hair follicle regression through the progression of cell death.Yudai Joko, Yoko Yamamoto, Shigeaki Kato
|Jul 28, 2023
Abaloparatide dose-dependently increases bone mineral density in postmenopausal women with osteoporosis: a phase 2 study.Toshio Matsumoto, Teruki Sone, Akiko Yamashita
|Jan 21, 2023
The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2.Yoshiki Higa, Masahiro Hiasa, Hirofumi Tenshin
|Nov 24, 2022
Osteoblast/osteocyte-derived interleukin-11 regulates osteogenesis and systemic adipogenesis.Bingzi Dong, Masahiro Hiasa, Yoshiki Higa
|Aug 17, 2022
Abaloparatide Increases Lumbar Spine and Hip BMD in Japanese Patients With Osteoporosis: The Phase 3 ACTIVE-J Study.Toshio Matsumoto, Teruki Sone, Satoshi Soen
Pageof 2
Frequent Collaborators
2 joint publications
Shigeaki Kato
2 joint publications
Itsuro Endo
2 joint publications
Shun Sawatsubashi
1 joint publications
Naoki Okubo
1 joint publications
Shigeyuki Matsui
1 joint publications
Toshitsugu Sugimoto
1 joint publications
Ko Watanabe
1 joint publications
Hideo Takami
1 joint publications
Masataka Shiraki
1 joint publications
Nobukazu Okimoto
